Key topics in molecular docking for drug design

PHM Torres, ACR Sodero, P Jofily… - International journal of …, 2019 - mdpi.com
Molecular docking has been widely employed as a fast and inexpensive technique in the
past decades, both in academic and industrial settings. Although this discipline has now had …

Application of MM-PBSA methods in virtual screening

G Poli, C Granchi, F Rizzolio, T Tuccinardi - Molecules, 2020 - mdpi.com
Computer-aided drug design techniques are today largely applied in medicinal chemistry. In
particular, receptor-based virtual screening (VS) studies, in which molecular docking …

Machine learning-based virtual screening for the identification of CDK5 inhibitors

M Di Stefano, S Galati, G Ortore, I Caligiuri… - International Journal of …, 2022 - mdpi.com
Cyclin-dependent kinase 5 (Cdk5) is an atypical proline-directed serine/threonine protein
kinase well-characterized for its role in the central nervous system rather than in the cell …

Improving structure-based virtual screening performance via learning from scoring function components

GL Xiong, WL Ye, C Shen, AP Lu… - Briefings in …, 2021 - academic.oup.com
Scoring functions (SFs) based on complex machine learning (ML) algorithms have gradually
emerged as a promising alternative to overcome the weaknesses of classical SFs. However …

Lin_F9: a linear empirical scoring function for protein–ligand docking

C Yang, Y Zhang - Journal of chemical information and modeling, 2021 - ACS Publications
Molecular docking is one of the most widely used computational tools in structure-based
drug design and is critically dependent on accuracy and robustness of the scoring function …

Integrating computational methods guided the discovery of phytochemicals as potential Pin1 inhibitors for cancer: pharmacophore modeling, molecular docking, MM …

AA Alzain, FA Elbadwi, TH Shoaib, AE Sherif… - Frontiers in …, 2024 - frontiersin.org
Pin1 is a pivotal player in interactions with a diverse array of phosphorylated proteins closely
linked to critical processes such as carcinogenesis and tumor suppression. Its axial role in …

[HTML][HTML] Enhanced activity of a pluronic F127 formulated Pin1 inhibitor for ovarian cancer therapy

G Saorin, M Mauceri, E Cavarzerani, I Caligiuri… - Journal of Drug Delivery …, 2023 - Elsevier
Worldwide cancer is the second cause of death exceeded only by cardiovascular diseases
[1]. Ovarian cancer is the fifth cause of death in women and the principal of gynaecological …

Virtual screening and crystallographic studies reveal an unexpected γ-lactone derivative active against MptpB as a potential antitubercular agent

G Cazzaniga, M Mori, F Meneghetti, LR Chiarelli… - European Journal of …, 2022 - Elsevier
Mycobacterial resistance is a rapidly increasing phenomenon requiring the identification of
new drugs effective against multidrug-resistant pathogens. The inhibition of protein tyrosine …

[HTML][HTML] pH-sensitive niosomes for ATRA delivery: A promising approach to inhibit Pin1 in high-grade serous ovarian cancer

MV Giuli, PN Hanieh, J Forte, MG Fabiano… - International Journal of …, 2024 - Elsevier
The peptidyl-prolyl cis/trans isomerase Pin1 positively regulates numerous cancer-driving
pathways, and it is overexpressed in several malignancies, including high-grade serous …

Pin1: Advances in pancreatic cancer therapeutic potential and inhibitors research

N Wang, T Chai, XR Wang, YD Zheng, CY Sang… - Bioorganic …, 2024 - Elsevier
The peptidyl-prolyl cis/trans isomerase NIMA-interaction 1 (Pin1) catalyzes the transition of
the proline ring from the cis to trans conformation, resulting in conformational and functional …